SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007811
Filing Date
2022-05-05
Accepted
2022-05-05 16:07:14
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20220331.htm   iXBRL 10-Q 2802898
2 EX-10.1 vir-ex10_1.htm EX-10.1 144899
3 EX-31.1 vir-ex31_1.htm EX-31.1 22907
4 EX-31.2 vir-ex31_2.htm EX-31.2 23710
5 EX-32.1 vir-ex32_1.htm EX-32.1 14085
  Complete submission text file 0000950170-22-007811.txt   10812202

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20220331_cal.xml EX-101.CAL 62228
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20220331_pre.xml EX-101.PRE 491145
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20220331_def.xml EX-101.DEF 358898
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20220331_lab.xml EX-101.LAB 689930
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20220331.xsd EX-101.SCH 100190
63 EXTRACTED XBRL INSTANCE DOCUMENT vir-20220331_htm.xml XML 1736578
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 22896214
SIC: 2836 Biological Products, (No Diagnostic Substances)